Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
8 papers
Recent·Most cited
A. Pormohammad, M. Moradi, J. W. Hommes, E. Pujol, L. M. J. Naesens, S. Vazquez, B. G. Surewaard, M. Zarei, M. Vazquez-Carrera, R. J. Turner
The paper evaluates novel pentafluorosulfanyl-containing triclocarban analogs, finding they effectively kill Gram-positive bacteria at low concentrations compared to common antibiotics.
bioRxiv · Jan 4, 2024Microbiology
M. Zarei, O. Hajihassani, J. J. Hue, H. J. Graor, L. D. Rothermel, J. M. Winter
This study shows that targeting wild-type IDH1 enhances chemosensitivity in pancreatic cancer by disrupting redox balance and increasing ROS-induced apoptosis.
bioRxiv · Mar 29, 2023Cancer Biology
J. J. Hue, M. Zarei, H. J. Graor, O. Hajihassani, E. S. Katayama, A. W. Loftus, A. Vaziri-Gohar, J. M. Winter
The paper provides detailed surgical techniques for orthotopic and splenic injections in a murine model of pancreatic cancer to improve preclinical research accuracy.
bioRxiv · Jul 30, 2022 · PreprintCancer Biology
W. Zhang, M. Wright, M. Rathore, M. Zarei, A. Vaziri-Gohar, J. Winter, J. Brody, R. Wang
This study shows liver endothelial cells promote PDAC growth via HER3-AKT signaling, suggesting HER3-targeted therapies for HER3-positive metastatic PDAC.
bioRxiv · Jun 24, 2022 · PreprintCancer Biology
M. Zarei, O. Hajihassani, J. J. Hue, H. J. Graor, M. Rathore, A. Vaziri-Gohar, J. M. Asara, J. M. Winter, L. D. Rothermel
This study shows that inhibiting wild-type IDH1 enhances chemotherapy response in melanoma by reducing redox homeostasis and increasing reactive oxygen species.
bioRxiv · May 13, 2022Cancer Biology
A. Vaziri-Gohar, J. J. Hue, H. J. Graor, A. Abbas, M. Zarei, O. Hajihassani, G. Titomihelakis, J. Feczko, M. Rathore, R. Wang, M. Zarei, M. Goudarzi, R. Zhang, B. Willard, L. Zhang, , J. M. Winter
This study shows that high glucose levels increase the effectiveness of chemotherapy in pancreatic cancer by reducing glutathione biosynthesis, which enhances oxidative stress in cancer cells.
bioRxiv · Apr 29, 2022Cancer Biology
A. Vaziri-Gohar, J. J. Hue, H. J. Graor, E. Prendergast, V. Chen, J. Cassel, F. S. Mohammed, A. Abbas, K. Dukleska, I. Khokhar, O. Hajhassani, M. Zarei, R. Wang, L. D. Rothermel, I. Bederman, , J. M. Winter
This study shows that wild-type IDH1 is a metabolic target in pancreatic cancer cells under nutrient limitation, and FDA-approved drugs can inhibit it effectively in preclinical models.
bioRxiv · Nov 19, 2020 · PreprintCancer Biology
S. M. Auwal, N. Zainal Abidin, M. Zarei, C. P. Tan, N. saari
The paper identifies five novel ACE-inhibitory peptides from stone fish hydrolysates and validates their mechanism through molecular docking.
bioRxiv · May 8, 2018Biochemistry